How often does the FDA update HRT research

DISCLOSURE: Voshell's Pharmacy is a licensed compounding pharmacy that prepares and sells compounded medications by prescription. As a provider of competing products, our perspective may be influenced by our professional and commercial interests.

According to FDA.gov, the FDA does not update HRT information on a fixed schedule. Instead, it reviews and updates information whenever new, solid evidence becomes available. This may happen several times a year or not for a stretch of time, depending on the flow of new data.

How FDA updates actually happen

According to FDA.gov, the FDA does not run its own regular HRT research program. Instead, it relies on:

• New clinical studies published in medical journals.
• Post‑marketing safety reports (real‑world side‑effect reports from doctors, patients, and manufacturers).
• Updated analyses submitted by pharmaceutical companies when they see new patterns in safety or effectiveness.
• Independent research from universities, women’s health organizations, and government groups.

When new, credible evidence emerges, the FDA reviews it. If the data are strong enough, the agency may update drug labels, warnings, recommended doses, or patient information. Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing and are prepared by a licensed pharmacist only in response to a valid prescription for an individual patient. This page primarily discusses commercially available hormone therapy products.

How often do HRT updates usually occur?

• There is no predetermined interval. Updates occur as needed.
• In practice, according to FDA Drug Safety Communications, major updates to HRT labels happen every few years when meaningful new safety data appear.
• Smaller updates or clarifications may happen multiple times a year across different products.

According to the FDA-approved prescribing information for hormone therapy products, most changes are driven by new research on breast cancer risk, cardiovascular risk, clotting risk, and optimal dosing or delivery methods (patch, gel, pill, ring).

What this means for women using HRT

• The information a qualified prescriber uses is continuously refreshed, not frozen in time.
• According to NAMS, large, high‑quality studies may lead to label updates that clarify safety information for hormone therapy.
• You do not need to monitor FDA files yourself; a qualified prescriber stays aligned with these changes through professional updates.

So while there is no fixed calendar, according to FDA.gov the FDA’s monitoring is ongoing and active, ensuring women have up‑to‑date safety information about commercially available hormone therapy. Consult a qualified prescriber for guidance on your individual situation.